EVACEF-S

Main information

  • Trade name:
  • EVACEF-S VIAL INJ
  • Dosage:
  • 1000,500;MG
  • Pharmaceutical form:
  • INJ
  • Composition:
  • VIAL
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • EVACEF-S VIAL INJ
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

4-1-2018

Ampicillin and Sulbactam for Injection USP 1.5 g/vial by Auromedics: Recall - Presence of Glass Particles in Vial

Ampicillin and Sulbactam for Injection USP 1.5 g/vial by Auromedics: Recall - Presence of Glass Particles in Vial

Administration of glass particulate may result in local irritation or swelling in response to the foreign material. More serious potential outcomes would include blockage and clotting in blood vessels, which may be life-threatening.

FDA - U.S. Food and Drug Administration

3-1-2018

Auromedics Pharma LLC Issues Voluntary Nationwide Recall of Product Ampicillin and Sulbactam for Injection USP 1.5 g/ Vial, Due to Presence of Glass Particles in the Vial

Auromedics Pharma LLC Issues Voluntary Nationwide Recall of Product Ampicillin and Sulbactam for Injection USP 1.5 g/ Vial, Due to Presence of Glass Particles in the Vial

AuroMedics Pharma LLC is voluntarily recalling lot AFO l 17001-A, Expiry date Dec 2018, of Ampicillin and Sulbactam for Injection USP, 1.5 g (equivalent to 1 g ampicillin as the sodium salt plus 0.5 g Sulbactam as the sodium salt) in a Single-Dose vial, to the hospital level. The product has been found to contain glass particles.

FDA - U.S. Food and Drug Administration

23-1-2018

AMPICILLIN AND SULBACTAM Injection, Powder, For Solution [Sagent Pharmaceuticals]

AMPICILLIN AND SULBACTAM Injection, Powder, For Solution [Sagent Pharmaceuticals]

Updated Date: Jan 23, 2018 EST

US - DailyMed

21-12-2017

CEFOTAXIME Injection, Powder, For Solution [Wockhardt USA LLC.]

CEFOTAXIME Injection, Powder, For Solution [Wockhardt USA LLC.]

Updated Date: Dec 21, 2017 EST

US - DailyMed